Harvard Bioscience Q3 EPS $0.04 Misses $0.05 Estimate, Sales $27.418M Miss $28.67M Estimate

Harvard Bioscience (NASDAQ:HBIO) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.05 by 20 percent. This is unchanged from the same period last year. The company reported

Benzinga · 11/05/2019 21:02

Harvard Bioscience (NASDAQ:HBIO) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.05 by 20 percent. This is unchanged from the same period last year. The company reported quarterly sales of $27.418 million which missed the analyst consensus estimate of $28.67 million by 4.37 percent. This is a 4.51 percent decrease over sales of $28.713 million the same period last year.